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Abstract
We investigated whether the specific binding or labeling of 125I-v-CgTX on crude membranes from chick whole brain
 .  .was affected when endogenous GTP binding protein G protein was activated by GTP analogues, mastoparan MP and
 y .  .aluminum fluoride AlF ; AlCl qNaF . Both GTPg S and Gpp NH p attenuated the inhibitory effect of selective N-type4 3
 .  . . 125Ca channel inhibitors such as aminoglycoside antibiotics AGs or dynorphine 1-13 Dyn on specific I-v-CgTX binding
in a dose-dependent manner. On the other hand, the inhibitory effects of the divalent metal cations Cd2q, Co2q, Mg2q and
Mn2q on such binding were not attenuated by GTPg S. MP and AlFy also attenuated the inhibitory effect of Neo on this4
binding similar to GTPg S. The attenuating effect of MP was enhanced by the presence of Mg2q in a dose-dependent
manner. However, GTP analogues, MP and AlFy, did not affect binding or labeling without AGs or Dyn. GTPg S, MP and4
AlFy also attenuated the specific labeling of a 215-kDa band in crude membranes with 125I-v-CgTX using the cross-linker4
 .DSS non-reduced condition in the presence of Neo. These results indicate that there are direct or indirect relationships
between N-type Ca channels and G proteins via binding sites for AGs or MP.
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1. Introduction
 .Voltage-sensitive calcium channels Ca channels
are widely distributed in excitable cells and play a
fundamental role in regulating many intracellular pro-
w xcesses 1–3 . Electrophysiological and pharmacologi-
cal studies have revealed the presence of four types
of Ca channels in neuronal tissue: i.e., L-, N-, P- and
w xT-type Ca channels 4–6 .
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 .Omega-conotoxin GVIA v-CgTX , which was
isolated from the venom of the marine snail Conus
w xgeographus 7 , specifically blocks calcium currents
w xthrough neuron-specific Ca channels 8–12 . This
toxin appears to act on neuronal N-type Ca channels
w x9,11,13,14 .
The characteristics of specific 125I-v-CgTX bind-
ing to chick and rat brain membranes have also been
w xinvestigated 15–20 . The molecular masses of v-
CgTX binding sites have been determined by photo-
w xaffinity labeling in rat brain membranes 21–23 and
by chemical cross-linking in chick brain membranes
w x23,24 . We previously reported that bands of 135
 . kDa reduced condition and 215 or 216 kDa non-re-
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. 125duced condition are selectively labeled with I-v-
CgTX using the cross-linker disuccinimidyl suberate
 . w xDSS or dithio bis succinimidyl propionate in chick
w xwhole brain 17,20,25 .
A family of membrane-associated guanine nu-
 .cleotide-binding regulatory proteins G proteins is
essential for mediating signal transduction between
cell-surface receptors and effectors such as adenylate
cyclase, phospholipase A , phospholipase C and ion2
w xchannels 26–29 . A wide variety of neurotrans-
mitters and hormones inhibit neuronal Ca2q currents,
and it is thought that this is a general mechanism for
controlling the release of neurotransmitters at presy-
w xnaptic terminals 30 . N-type Ca channels also serve
w xas a target for transmitter-induced inhibition 9,31 .
The receptor-mediated inhibition of N-type Ca chan-
w xnels requires the activation of G proteins 32,33 .
These reports suggest that if N-type Ca channels are
directly or indirectly related to G proteins, the spe-
cific binding of 125I-v-CgTX may be affected by the
activation of G proteins.
w xStumpo et al. 34 reported that the inhibition
 .curves of the aminoglycoside antibiotic AG
 . 125neomycin sulfate Neo on I-v-CgTX-binding to
hippocampal membranes from rat brain were shifted
to the right by GTP analogues or fluoride, and indi-
cated that the inhibition of 125I-v-CgTX-binding by
Neo may be mediated by a G protein.
In this study, to clarify the relationship between
the two on crude membranes from chick whole brain,
wwe examined the effects of G protein activators 35–
x w x  .38 such as GTP analogues 35,36 , mastoparan MP
w x y w x37 and aluminum fluoride AlF ; AlCl qNaF 384 3
on specific 125I-v-CgTX binding or 125I-v-CgTX la-
beling in the absence or presence of selective in-
hibitors of N-type Ca channels such as AGs and
 .  . w x.dynorphine 1-13 Dyn 20 .
A preliminary report of part of this work has
w xappeared previously in abstract form 39 .
2. Materials and methods
2.1. Preparation of crude membranes
Crude membranes were prepared from whole brain
w xof 5-day-old chicks as described previously 20 ,
except that the final precipitate was suspended with
 .10 mM 4 2-hydroxyethyl -1-piperazine ethane sul-
 .  .fonic acid Hepes -NaOH pH 7.4 at 48C .
2.2. Assay of 125I-v-CgTX binding
Specific binding of 125I-v-CgTX to crude mem-
branes was assayed by the method of Ichida et al.
w x 20 , except that 30 mM Hepes-NaOH pH 7.4 at
.308C was used in the assay medium, the concentra-
tion of the crude membranes in the assay medium
was about 25 mg of proteinrtube unless otherwise
indicated, and the reaction for specific 125I-v-CgTX
binding was carried out for 90 min at 308C.
Fig. 1. Effect of GTPg S on specific 125I-v-CgTX binding as a
function of the concentration of AGs. Panels A, B, C and D show
the effects of Ami, Neo, Str and Tob, respectively, in the absence
 .  .filled circle and presence empty circles of 200 mM GTPg S.
Points represent the means of 5–8 preparations from separate
animals. Bars indicate standard errors. )P -0.05, )) P -0.02
and ))) P -0.01 vs. binding in the absence of GTPg S.
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 . 125  .  .Fig. 2. Effects of GTP analogues 200 mM on specific I-v-CgTX binding in the absence panel A and presence panel B of 10 mM
Neo. Columns represent the means for 6–8 preparations from separate animals. Bars indicate standard errors. ) P-0.05 vs. control.
For experiments on the effects of GTP analogues,
MP and AlFy in the absence and presence of AGs or4
Dyn, these agents were added to the assay medium
before the binding reaction was started by adding the
crude membranes.
The specific binding of 125I-v-CgTX was defined
as the difference between the radioactivities bound in
 . the absence total binding and presence non-specific
.binding of unlabeled v-CgTX at 1000-fold the con-
centration of 125I-v-CgTX.
2.3. Reaction for cross-linking
Specific binding of 125I-v-CgTX was assayed as
described in Section 2.2 with the following modifica-
tion: 80-ml aliquots of the crude membranes about
300 mg proteinrtube; the concentration of the crude
membranes was adjusted to about 3.75 mg
.proteinrml were added to the assay medium before
the binding reaction was started.
After the specific binding of 125I-v-CgTX to the
crude membranes was carried out for 90 min at 308C,
cross-linking of 125I-v-CgTX with DSS to its binding
w xsites was assayed by the method of Ichida et al. 20 .
The concentration of DSS was 500 mM, and the
incubation time for the cross-linking reaction was 1.5
min at 228C. After the cross-linking reaction was
stopped by the addition of 1.2 ml of 100 mM Tris-HCl
 .pH 8.5 at 228C , centrifugation, SDS-PAGE under
non-reduced conditions and autoradiography were
w xcarried out as reported previously 20 .
2.4. Other methods
Protein was measured by the method of Lowry et
w xal. 40 with BSA as a standard.
Statistical analyses were performed using the paired
or unpaired Student’s t-test and multiple groups were
evaluated by a one-way analysis of variance. A P-
Fig. 3. Specific 125I-v-CgTX binding in the presence of 10 mM
 .Neo as a function of the concentration of GTPg S panel A or
 .  .Gpp NH p panel B . Points represent the means of 5 prepara-
tions from separate animals. Bars indicate standard errors. ) P -
)) 0.05, P -0.01 vs. binding in the absence of GTPg S panel
.  .  .A or Gpp NH p panel B .
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value of less than 0.05 was considered statistically
significant.
2.5. Materials
125  .I-v-CgTX 81.4 TBqrm mol was purchased
from Amersham or New England Nuclear Co. DSS
 .was purchased from Pierce Co Rockford, IL .
 .Dynorphine 1-13 , mastoparan and v-CgTX were
 .from Peptide Institute, Inc. Osaka, Japan . Amikacin
 .  .  .Ami , neomycin Neo , streptomycin Str and to-
 .  .bramycin Tob were from Sigma St. Louis, MO ,
 .  .Nakalai Kyoto, Japan or Wako Osaka, Japan .
Aluminum chloride, cadmium chloride, cobalt dichlo-
ride, magnesium chloride, manganese chloride and
 .sodium fluoride were from Wako Osaka, Japan .
 .GDP and GTP were from Yamasa Tokyo, Japan .
X  . XGuanosine 5 -O-2-thiodiphosphate GDP-b-S , 5 -
w  . xguanylimidodiphosphate Gpp NH p and guanosine
X  .5 -O-3-thiotriphosphate GTPg S were from
 .Boehringer Mannheim Mannheim, Germany . U-
50488H was a gift from Dr. A. Kawabata Kinki
.University .
3. Results
3.1. Effects of GTP analogues
 .GTPg S 200 mM attenuated the inhibitory effects
 .of AGs Ami, Neo, Str and Tob at various concen-
trations on the specific binding of 125I-v-CgTX, as
shown in Fig. 1A–D. When the percent inhibition by
an AG was more than about 30%, the attenuating
effect of GTPg S was particularly significant. The
attenuating effect of GTPg S was observed, but those
 .of other GTP analogues 200 mM such as GTP,
 .Gpp NH p and GDP was not significantly observed
 . Fig. 2B . On the other hand, GTP analogues 200
.mM had no significant effect in the absence of 10
 .mM Neo Fig. 2A . The attenuating effect of GTPg S
 .  .or Gpp NH p was dose-dependent Fig. 3A . Note
 .that Gpp NH p at a concentration of more than 400
mM significantly attenuated the inhibitory effect of
 .10 mM Neo Fig. 3B , and the attenuating effect of
 .Gpp NH p was weaker than that of GTPg S.
Fig. 4B shows the autoradiographic pattern for the
 .effect of GTP analogues 500 mM on the inhibitory
125  .  .Fig. 4. Effects of GTP analogues on I-v-CgTX labeling in the absence panel A or presence panel B of 100 mM Neo. GTP and GTP
 .  .analogues were used at a final concentration of 500 mM. The symbols y and q indicate the absence and presence of unlabeled
125I-v-CgTX, at 1000-fold the concentration of 125I-v-CgTX, in the reaction medium, respectively. The arrowheads in panels A and B
indicate the 215-kDa band.
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effect of 100 mM Neo on specific 125I-v-CgTX
labeling with the cross-linker DSS. GTPg S only at-
tenuated the inhibitory effect of 100 mM Neo on
specific 125I-v-CgTX labeling to the 215-kDa band.
In the absence of Neo, however, none of the GTP
analogues affected labeling to the 215-kDa band Fig.
.4A . The concentrations of GTP analogues and Neo
used in this labeling experiment were different from
those used in the binding experiment because 10 mM
Fig. 5. Panel A shows the effect of 200 mM GTPg S on specific
125I-v-CgTX binding in the presence of 10 mM Neo as a
function of the concentration of protein in the tube. Columns
represent the means for 4 preparations from separate animals.
Bars indicate standard errors. )P -0.05 vs. binding in the ab-
sence of GTPg S. Panel B shows the effects of 200 and 500 mM
GTPg S on specific 125I-v-CgTX binding as a function of the
concentration of Neo. The concentration of protein from chick
crude membranes is 300 mg of proteinrtube. In both panels A
and B, points represent the means of 4–6 preparations from
separate animals. Bars indicate standard errors. )P -0.05, )) P
-0.01 vs. binding in the absence of GTPg S.
Neo andror 200 mM GTPg S did not have any effect
 .on labeling data not shown . After further experi-
ments, it became clear that the reason for this differ-
ence involved a difference in the protein concentra-
tions of the crude membranes; i.e., binding used 25
mg of proteinrtube and labeling used 300 mg of
 .proteinrtube see Section 2 . As shown in Fig. 5A,
the attenuating effect of 200 mM GTPg S in the
presence of 10 mM Neo on binding disappeared at a
protein concentration higher than 75 mgrtube. To
demonstrate inhibitory and attenuating effects on la-
beling, higher concentrations of Neo and GTPg S,
 .such as 100 and 500 mM, were needed Fig. 5B .
The inhibitory effect of Dyn at various concentra-
tions on specific 125I-v-CgTX binding was also sig-
 .nificantly attenuated by 200 mM GTPg S Fig. 6A .
We previously reported that AGs and Dyn were
selective blockers of specific 125I-v-CgTX binding
w x20 ; therefore, the attenuating effect for Dyn instead
of AG was examined. It is possible that the attenuat-
ing effect of GTPg S is mediated by k-opiate recep-
tors, although we previously reported that the in-
hibitory effect of Dyn was not due to an opiate-re-
w xlated mechanism 20 . To assess this possibility, the
effect of U-50488H, a k-opiate receptor agonist, was
examined, as shown in Fig. 6B. U-50488H at concen-
trations of 3=10y6–10y4 M did not affect specific
125I-v-CgTX binding in the absence or presence of
200 mM GTPg S.
To investigate the selectivity of the attenuating
effect of GTPg S, the inhibitory effects of various
divalent metal ions were examined in the absence and
 .  .presence of GTPg S Fig. 7A–D . GTPg S 200 mM
did not attenuate the inhibitory effects of various
concentrations of the divalent metal ions Cd2q, Co2q,
Mg2q and Mn2q.
3.2. Effect of MP
Thirty mM MP or 30 mM MP plus 1 mM MgCl2
significantly attenuated the inhibitory effect of Neo
on specific 125I-v-CgTX binding, as shown in Fig. 8,
and this attenuating effect of MP was dose-dependent
 .Fig. 9A . The attenuating effect of MP was en-
hanced in the presence of 1 mM MgCl , and this2
enhancement by MgCl was also dose-dependent2
 .Fig. 9B .
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125  .Fig. 6. Effect of 200 mM GTPg S on specific I-v-CgTX binding as a function of the concentration of Dyn panel A or U-50488H
 . ) ))panel B . Points represent the means of 5–8 preparations from separate animals. Bars indicate standard errors. P-0.05, P-0.01
vs. binding in the absence of GTPg S.
Fig. 7. Effect of 200 mM GTPg S on specific 125I-v-CgTX
2q  .binding as a function of the concentration of Cd panel A ,
2q  . 2q  . 2q  .Co panel B , Mg panel C or Mn panel D . Points
represent the means of 4–6 preparations from separate animals.
Bars indicate standard errors.
The inhibitory effect of 100 mM Neo on specific
125I-v-CgTX labeling to the 215-kDa band with DSS
was attenuated by 300 mM MP or 300 mM MP plus
1 mM MgCl in the presence of 100 mM Neo Fig.2
.10 . The result shown in Fig. 10 was consistent with
that for the attenuating effect of MP or MP plus
MgCl on specific 125I-v-CgTX binding, although2
different concentrations of MP were used.
The inhibitory effect of Dyn at various concentra-
Fig. 8. Effect of 30 mM MP on specific 125I-v-CgTX binding in
the absence and presence of 1 mM Mg2q as a function of the
concentration of Neo. Points represent the means of 5–7 prepara-
tions from separate animals. Bars indicate standard errors. ) P -
0.05 vs. binding in the absence of MP and Mg2q.
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Fig. 9. Panel A shows specific 125I-v-CgTX binding in the
presence of 10 mM Neo as a function of the concentration of
MP. Panel B shows specific 125I-v-CgTX binding in the presence
of 10 mM Neo plus 30 mM MP as a function of the concentra-
tion of Mg2q. In both panels A and B, points represent the means
of 3–5 preparations from separate animals. Bars indicate standard
)  .errors. P -0.05 vs. binding in the absence of MP panel A or
2q  .Mg panel B .
tions on specific 125I-v-CgTX binding was also sig-
nificantly attenuated by 30 mM MP plus 1 mM
MgCl , as shown in Fig. 11. MP shifted the inhibi-2
tion curve of Dyn not only rightwards, but also
upwards. The curve of the attenuating effect of MP
on the inhibitory effect of Dyn was comparable to
 .that of Neo Fig. 6A .
Fig. 10. Effects of 300 mM MP or 300 mM MP plus 1 mM
Mg2q on 125I-v-CgTX labeling in the presence of 100 mM Neo.
 .  .The symbols y and q indicate the absence and presence of
unlabeled 125I-v-CgTX, at 1000-fold the concentration of 125I-
v-CgTX, in the reaction medium, respectively. The arrowheads
in panels A and B indicate the 215-kDa band.
Fig. 11. Effect of 30 mM MP on specific 125I-v-CgTX binding in
the absence and presence of 1 mM Mg2q as a function of the
concentration of Dyn. Points represent the means of 5–8 prepara-
tions from separate animals. Bars indicate standard errors. ) P -
0.05, )) P -0.02 and ))) P -0.01 vs. binding in the absence
of MP and Mg2q.
3.3. Effect of AlF y4
y  .AlF 100 mM AlCl plus 50 mM NaF signifi-4 3
cantly attenuated the inhibitory effect of Neo on
specific 125I-v-CgTX binding, as shown in Fig. 12,
y  .Fig. 12. Effect of AlF 100 mM AlCl plus 50 mM NaF on4 3
specific 125I-v-CgTX binding as a function of the concentration
of Neo. Points represent the means of 5–7 preparations from
separate animals. Bars indicate standard errors. ) P -0.01 vs.
binding in the absence of AlFy.4
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Fig. 13. Panel A shows specific 125I-v-CgTX binding in the
presence of 10 mM Neo plus 100 mM AlCl as a function of the3
concentration of NaF. Panel B shows specific 125I-v-CgTX bind-
ing in the presence of 10 mM Neo plus 50 mM NaF as a function
of the concentration of AlCl . In both panels A and B, points3
represent the means of 3–5 preparations from separate animals.
Bars indicate standard errors. ) P -0.01 vs. binding in the
 .  .absence of NaF panel A or AlCl panel B , respectively.3
and this attenuating effect by AlFy was dose-depen-4
dent for NaF in the presence of 100 mM AlCl Fig.3
.13A . However, the inhibitory effect of 10 mM Neo
was not changed by 10–1000 mM AlCl in the3
 .presence of 50 mM NaF Fig. 13B . The attenuating
y  .effect of AlF 100 mM AlCl plus 50 mM NaF4 3
was also significantly increased by 1 mM GDP Fig.
.14 .
The inhibitory effect of 100 mM Neo on specific
y  .Fig. 14. Effect of AlF 100 mM AlCl plus 50 mM NaF on4 3
specific 125I-v-CgTX binding in the presence of 10 mM Neo as a
function of the concentration of GDP. Points represent the means
of 5 preparations from separate animals. Bars indicate standard
errors.
) P -0.05 vs. binding in the absence of GDP.
y  .Fig. 15. Effect of AlF 100 mM AlCl plus 100 mM NaF on4 3
125I-v-CgTX labeling in the presence of 100 mM Neo. The
 .  .symbols y and q indicate the absence and presence of
unlabeled 125I-v-CgTX, at 1000-fold the concentration of 125I-
v-CgTX, in the reaction medium, respectively. The arrowheads
in panels A and B indicate the 215-kDa band.
125I-v-CgTX labeling to the 215-kDa band with DSS
y was attenuated by AlF 100 mM AlCl plus 1004 3
.mM NaF , as shown in Fig. 15. This result was
consistent with that for the attenuating effect of AlFy4
on specific 125I-v-CgTX binding, although different
concentrations of NaF were used.
The inhibitory effect of Dyn at various concentra-
tions on specific 125I-v-CgTX binding was also sig-
y nificantly attenuated by AlF 100 mM AlCl plus4 3
. y50 mM NaF , as shown in Fig. 16. AlF shifted the4
inhibition curve for Dyn not only rightward, but also
y  .Fig. 16. Effect of AlF 100 mM AlCl plus 50 mM NaF on4 3
specific 125I-v-CgTX binding as a function of the concentration
of Dyn. Points represent the means of 5–7 preparations from
separate animals. Bars indicate standard errors. )P -0.05, )) P
-0.01 vs. binding in the absence of AlFy.4
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upward. The curve for the attenuating effect of AlFy4
on the inhibitory effect of Dyn was comparable to
 .that of Neo Fig. 6A and Fig. 11 .
4. Discussion
N-type Ca channels are known to be a target for
the neurotransmitter-induced inhibition of neuronal
w xcalcium currents 9,31 . In this case, the activation of
G proteins is required for the neurotransmitter-
w xmediated inhibition of N-type Ca channels 32,33 . It
has been reported that the venom of a marine snail,
v-CgTX, selectively blocks calcium current in neural
w xN-type Ca channels 8–14 . Based on these experi-
ments, it is reasonable to consider that specific 125I-
v-CgTX binding on crude membranes from the brain
may be affected under the activation of G protein. In
this study, we investigated whether specific 125I-v-
CgTX binding on crude membranes from chick whole
brain was affected when G protein in the crude
membranes was activated by GTPg S, MP or AlFy4
w x35–38 .
 .GTPg S 200 mM attenuated the inhibitory effect
of various AGs; their IC values increased from50
5–30 mM to 25–150 mM. This result is comparable
w xto that of Stumpo et al. 34 , although they investi-
gated only the effect of Neo, and its IC value was50
lower than that in our study.
 .Gpp NH p also attenuated the inhibitory effect of
 .Neo in a dose-dependent manner Fig. 3B , but this
effect was very weak compared to that of GTPg S
 .Fig. 3A . GTPg S is known to have several irre-
versible effects in the hormone-activated adenylate
cyclase system which are not observed with
 . w x w xGpp NH p 41 . Citri and Schramm 41 also reported
 .that Gpp NH p, but not G , competed with GGTPg S GDP
for b-adrenergic receptor, so that G could beGPPNHP
converted back to the inactive form G , but GGDP GTPg S
could not. Therefore, the difference in the attenuating
 .effect between GTPg S and Gpp NH p may be due to
the difference in the characteristics between G pro-
 .tein combined with GTPg S and Gpp NH p.
 .GTPg S 200 mM also had an attenuating effect
on inhibition by Dyn, suggesting that the attenuating
effect of GTPg S was not specific for inhibition by
AGs, although the attenuation curve for GTPg S on
the inhibitory effect of Dyn was different from that
for AGs. It seems likely based on these results that
while the inhibitory effect of Dyn is also mediated by
G protein, the mechanism is not the same as that of
Neo because the curves for the attenuating effects of
GTPg S, MP and AlFy on the inhibitory effect of4
Dyn were different from those for Neo.
We previously suggested that the inhibitory effect
of Dyn on specific 125I-v-CgTX binding to crude
membranes was not due to a mechanism involving
w xk-opiate receptors 20 . In this study, we also ob-
served that the k-agonist U50488H at concentrations
of 3=10y5 M to 10y4 M did not affect specific
125I-v-CgTX binding in the absence or presence of
200 mM GTPg S. These findings suggest that the
effects of Dyn and GTPg S do not involve a k-
opiate-related mechanism.
The inhibitory effects of Cd2q, Co2q, Mg2q or
Mn2q on specific 125I-v-CgTX binding were not
 .attenuated by 200 mM GTPg S Fig. 7A–D . There-
fore, these results indicate that the inhibitory effect of
these divalent metal ions on binding was not medi-
ated by G protein, suggesting that the attenuating
effect of GTPg S was selective for the inhibitory
w xeffect of specific blockers such as AGs and Dyn 20
on
125I-v-CgTX binding.
MP, a toxin from wasp venom, is a potent secreta-
w xgogue. Higashijima et al. 37 suggested that MP
strongly promotes nucleotide exchange by G protein
w xto mimic agonist-liganded receptors. Bigay et al. 38
reported that AlFy, which acts as the a-subunit of G4
protein, mimics g-phosphate of GTP on G protein in
retinal membranes, since there are striking structural
similarities between AlFy and PO3y. Therefore, we4 4
used MP and AlFy as activators of G protein for4
specific 125I-v-CgTX binding.
MP attenuated the inhibitory effect of Neo similar
to GTPg S. This attenuating effect of MP was en-
hanced by the presence of Mg2q in a dose-dependent
manner, which again suggests that MP promotes
nucleotide exchange on G protein, since it has been
reported that receptor-catalyzed and non-receptor-
catalyzed nucleotide exchange on G protein require
micromolar levels and 10–100 mM Mg2q, respec-
w xtively 26 . In our work, however, the attenuating
effect of 30 mM MP on the inhibitory effect of 10
mM Neo was significantly enhanced by 1 mM Mg2q,
but inhibited by 10 mM Mg2q, as shown in Fig. 9.
Since a Mg2q concentration of more than 3 mM
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significantly inhibited specific 125I-v-CgTX binding
in the absence of MP and Neo, as shown in Fig. 7,
the enhancement of the attenuating effect of MP by
10 mM Mg2q disappeared, even if 10 mM Mg2q
accelerated the activation of G protein by MP.
We observed that AlFy attenuated the inhibitory4
effect of Neo or Dyn, and these results were similar
to those with GTPg S or MP. As suggested by Bigay
w xet al. 38 , GDP enhances the attenuating effect of
AlFy on the inhibitory effect of Neo or Dyn. How-4
ever, in our study, the enhancing effect of GDP in the
presence of AlFy was very small. The discrepancy4
between these results remains unresolved.
Ichida et al. suggested that the labeling of the
 . 135-kDa reduced condition or 215-kDa non-re-
. 125duced condition band with I-v-CgTX using the
cross-linker DSS involved specific binding sites of
125I-v-CgTX, perhaps including an N-type Ca chan-
nel subunit in the crude membranes from chick whole
w xbrain 20 . We previously reported that AGs and Dyn
selectively inhibited specific 125I-v-CgTX binding,
and also decreased labeling with 125I-v-CgTX using
w xDSS 20 . Therefore, we examined whether the label-
ing of the 215-kDa band with 125I-v-CgTX using
DSS was affected by GTPg S in the absence or
presence of Neo. First, the effect of Neo andror
GTPg S on this labeling was examined under the
same conditions as for specific 125I-v-CgTX binding,
but no attenuating effect of GTPg S on the inhibitory
effect of Neo was observed. The protein concentra-
tion of the crude membranes used in this labeling was
about 300 mg of proteinrtub, which is about 4 times
125 higher than that for specific I-v-CgTX binding 25
. w xmg of proteinrtube; see Section 2 20 . Therefore,
we again attempted labeling of 125I-v-CgTX after
determining the optimum concentrations of GTPg S
and Neo for affecting specific 125I-v-CgTX binding
under a high concentration of protein 300 mg of
. proteinrtube , as shown in Fig. 5B. GTPg S 500
.mM attenuated the inhibitory effect of 100 mM Neo
on specific 125I-v-CgTX labeling to the 215-kDa
 . 2qband. MP 300 mM in the presence of 1 mM Mg
y  .and AlF 100 mM AlCl q100 mM NaF also had4 3
an attenuating effect on such labeling in the presence
 .of 100 mM Neo Figs. 10 and 15 . These results
support the notion that labeling of the 215-kDa band
by 125I-v-CgTX involved specific binding sites for
125I-v-CgTX, and perhaps neuronal N-type Ca chan-
w xnels as reported previously 20 . In addition, the
amount of protein in the binding system appears to
influence the inhibitory effect of Neo or the attenuat-
ing effects of GTPg S, MP and AlFy, although the4
 .mechanism s is not yet clear.
These results indicate that there are direct or indi-
rect relationships between N-type Ca channels and
the binding sites of the selective antagonists AGs and
Neo that involve a G protein-related mechanism.
Recently, it was reported that 125I-v-CgTX sensi-
tive N type Ca channels interact with the proteins that
 . w xregulate neuronal exocytosis pathway s 42,43 , sug-
gesting that N type Ca channels have relation to a
mechanism of neurotransmitter release. If N type Ca
channels have relation to receptors of neurotrans-
mitters and to G protein in the synaptic plasma
membranes of presynapse area, neurotransmitters
over-released may be controlled with a mechanism
by which Ca influx through N type Ca channels are
inhibited by receptors of neurotransmitters following
G proteins, although we have no data to prove this
idea. Our finding may be relate to the mechanism of
neurotransmitter release.
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